Emea Solid Oral Nutraceutical Excipient Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 269,272.69 Thousand |
 Marktgröße (Prognosejahr) | USD 443,498.11 Thousand |
 CAGR |
% |
| Wichtige Marktteilnehmer |
>EMEA-Markt für feste orale Nutraceutical-Hilfsstoffe, nach Funktionalität (Bindemittel, Füllstoffe und Verdünnungsmittel, Suspensions- und Viskositätsmittel, Beschichtungen, Sprengmittel und andere), Formulierung (Tabletten, Kapseln, Gummis und andere), Endprodukt (Probiotika, Präbiotika, Protein- und Aminosäurepräparate, Vitaminpräparate, Mineralstoffpräparate, Omega-3-Präparate und andere Präparate), Hilfsstoffquelle (synthetisch und natürlich), Vertriebskanal (Direktausschreibung, Einzelhandelsverkauf und andere), Land (Deutschland, Italien, Großbritannien, Frankreich, Spanien, Belgien, Niederlande, Russland, Schweiz, Türkei, übriges Europa, Südafrika, Saudi-Arabien, Vereinigte Arabische Emirate, Algerien, Oman, Kuwait und übriger Naher Osten und Afrika) – Branchentrends und Prognose bis 2031.
EMEA: Marktanalyse und Einblicke für feste orale Nutraceutical-Hilfsstoffe
Der Markt für feste orale Nutraceutika-Hilfsstoffe in der EMEA-Region hat in den letzten Jahren ein stetiges Wachstum erlebt, das auf das zunehmende Gesundheits- und Wellnessbewusstsein der Verbraucher, die steigende Nachfrage nach Nahrungsergänzungsmitteln sowie Fortschritte bei der Formulierung von Arzneimitteln und Nutraceutika zurückzuführen ist. Hilfsstoffe sind bei der Entwicklung fester oraler Darreichungsformen von entscheidender Bedeutung und beeinflussen die Stabilität, Bioverfügbarkeit und Gesamtleistung von Nutraceutika-Produkten.
Zu den wichtigsten Faktoren, die zum Marktwachstum beitragen, zählen die zunehmende Alterung der Bevölkerung, die wachsende gesundheitsbewusste Verbraucherbasis und der Anstieg lebensstilbedingter Gesundheitsprobleme, die die Nachfrage nach Nahrungsergänzungsmitteln angeheizt haben. Auch regulatorische Initiativen und Standards in der EMEA-Region spielen eine wichtige Rolle bei der Gestaltung der Marktlandschaft, wobei die Hersteller auf die Einhaltung von Qualitäts- und Sicherheitsvorschriften achten.
Allerdings steht der Markt vor Herausforderungen wie strengen regulatorischen Anforderungen und der Notwendigkeit kontinuierlicher Innovationen.
Es wird erwartet, dass der Markt für feste orale Nutraceutical-Hilfsstoffe in der EMEA-Region im Prognosezeitraum von 2024 bis 2031 an Marktwachstum gewinnt. Data Bridge Market Research analysiert, dass der Markt im Prognosezeitraum von 2024 bis 2031 mit einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 6,6 % wächst und von 269.272,69 Tausend USD im Jahr 2023 auf 443.498,11 Tausend USD im Jahr 2031 ansteigen dürfte.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2024 bis 2031 |
|
Basisjahr |
2023 |
|
Historische Jahre |
2022 (anpassbar auf 2016–2021) |
|
Quantitative Einheiten |
Umsatz in Tausend USD und Volumen in Einheiten |
|
Abgedeckte Segmente |
Nach Funktionalität (Bindemittel, Füllstoffe und Verdünnungsmittel, Suspensions- und Viskositätsmittel, Beschichtungen, Sprengmittel und andere), Formulierung (Tabletten, Kapseln, Gummis und andere), Endprodukt (Probiotika, Präbiotika, Protein- und Aminosäurepräparate, Vitaminpräparate, Mineralstoffpräparate , Omega-3-Präparate und andere Präparate), Trägerstoffquelle (synthetisch und natürlich), Vertriebskanal (direkte Ausschreibung, Einzelhandelsverkauf und andere) |
|
Abgedeckte Länder |
Deutschland, Italien, Großbritannien, Frankreich, Spanien, Belgien, Niederlande, Russland, Schweiz, Türkei, übriges Europa, Südafrika, Saudi-Arabien, Vereinigte Arabische Emirate, Algerien, Oman, Kuwait und übriger Naher Osten und Afrika |
|
Abgedeckte Marktteilnehmer |
Ingredion, Azelis, JRS Pharma, BASF Corporation, Omya, Ashland, DuPont, Sigachi Industries, International Flavors & Fragrances Inc., Croda International Plc, Cargill, Incorporated., Grain Processing Corporation, Kerry Group plc, Roquette Frères, Colorcon, Bioground GmbH, BENEO (eine Tochtergesellschaft der Südzucker AG), Evonik Industries AG und SEPPIC unter anderem |
EMEA: Marktdefinition für feste orale Nutraceutika-Hilfsstoffe
Feste orale Nutraceutika-Hilfsstoffe sind nicht aktive Substanzen, die strategisch in die Formulierung von Ernährungsprodukten in Dosierungsformen wie Tabletten oder Kapseln eingearbeitet werden, um verschiedene funktionelle Rollen zu erfüllen. Diese Hilfsstoffe spielen eine zentrale Rolle im gesamten Produktentwicklungsprozess und tragen zu den physikalischen Eigenschaften, der Herstellbarkeit und der Leistung des endgültigen Nutraceutikums bei.
Dynamik des Marktes für feste orale Nutraceutika-Hilfsstoffe in der EMEA-Region
Treiber
- Steigende Nachfrage nach Nutraceuticals
Verbraucher greifen auf Nutraceutika zurück, da präventive Gesundheitsfürsorge und ein gesteigertes Gesundheitsbewusstsein immer wichtiger werden. Diese funktionellen Lebensmittel und Nahrungsergänzungsmittel gelten als gut geeignet, um bestimmte Gesundheitsprobleme zu lösen, Ernährungslücken zu schließen und die allgemeine Gesundheit zu verbessern. Die alternde Bevölkerung in der EMEA-Region ist ein Faktor für den Anstieg des Nutraceutikakonsums. Die Produkte, die die Knochengesundheit, die kognitiven Funktionen, das gesunde Altern und andere altersbedingte Probleme unterstützen, werden mit zunehmendem Alter immer beliebter.
Die Nachfrage der Verbraucher nach neuen und nützlichen Nutraceutika-Produkten treibt die Nachfrage nach innovativen Hilfsstoffen an, die Formulierungsinnovationen ermöglichen. Die Stabilisierung, Bioverfügbarkeit und der Transport der Wirkstoffe in diesen Produkten werden durch die Verwendung von Hilfsstoffen verbessert. Hilfsstoffe müssen dem Trend der Nutraceutika-Industrie zu natürlichen Inhaltsstoffen und sauberer Kennzeichnung entsprechen. Hersteller suchen nach Hilfsstoffen aus natürlichen Quellen oder solchen, die als sicher und hygienisch gelten, um sie in ihre Produkte einzubauen.
- Immer mehr Fortschritte bei Nutraceuticals-Hilfsstoffen
Der Bedarf an Hilfsstoffen, die dabei helfen können, diese Nutrazeutika effektiver zu formulieren und zu verabreichen, wächst mit der Ausweitung dieser Forschung. In Nutrazeutika spielen Hilfsstoffe eine entscheidende Rolle, um die Stabilität, Bioverfügbarkeit und Wirksamkeit der Wirkstoffe zu gewährleisten. Ihre Rolle ist entscheidend, um Forschungsergebnisse in praktikable und kommerziell tragfähige Formulierungen umzusetzen. Durch wissenschaftliche Studien, klinische Tests und laufende Forschungsbemühungen zur Bestimmung ihrer Wirksamkeit, Sicherheit und möglichen Anwendungen gewinnen Nutrazeutika neue Erkenntnisse über ihre gesundheitsfördernden Eigenschaften.
Daher ist zu erwarten, dass die zunehmenden Forschungsaktivitäten im Bereich Nutrazeutika das Marktwachstum vorantreiben.
Gelegenheit
- Wachsendes Gesundheitsbewusstsein in der Bevölkerung
Aufgrund dieses gestiegenen Bewusstseins suchen die Menschen eher nach funktionellen Mahlzeiten, Vitaminen und Nahrungsergänzungsmitteln, die ihren Ansprüchen an ihr Wohlbefinden gerecht werden. Die Nachfrage nach Nutraceutika ist infolgedessen gestiegen, und ihre Formulierung erfordert sichere und wirksame Trägerstoffe. Das Marktpotenzial wird durch das wachsende Interesse an Nahrungsergänzungsmitteln erhöht. Trägerstoffhersteller haben jetzt eine größere Verbraucherbasis und die Möglichkeit, Innovationen zu entwickeln und Trägerstoffe zu entwickeln, die speziell auf die Bedürfnisse dieser gesundheitsbewussten Verbraucher zugeschnitten sind.
Aufgrund der zunehmenden Bedeutung von Wellness und präventiver Gesundheitsfürsorge steigt die Nachfrage nach Nutraceutika wie Vitaminen, funktionellen Lebensmitteln und Nahrungsergänzungsmitteln. Diese Produkte werden häufig in fester oraler Darreichungsform angeboten, was bedeutet, dass bei der Formulierung gute Trägerstoffe verwendet werden müssen. Beim Kauf von Nutraceutika suchen gesundheitsbewusste Verbraucher nach einer Vielzahl spezialisierter Formulierungen.
Herausforderungen/ Einschränkungen
- Einhaltung gesetzlicher Vorschriften für Nutraceuticals-Hilfsstoffe
Die Komplexität ergibt sich aus der Notwendigkeit, in diesen Bereichen verschiedene Regulierungsstrukturen einzuhalten. Jedes EMEA-Land kann seine eigenen Vorschriften in Bezug auf zulässige Konzentrationen, Sicherheitsbewertungen, zulässige Hilfsstoffe und Kennzeichnungsspezifikationen haben. International tätige Unternehmen haben Schwierigkeiten, sich in diesem Regulierungsumfeld zurechtzufinden, da sie eine gründliche Kenntnis mehrerer Regulierungsrahmen und die Ressourcen benötigen, um Abläufe und Waren entsprechend anzupassen. Die regelmäßigen Aktualisierungen und Änderungen erschweren die Gesetzgebung zusätzlich. Es bedarf ständiger Anpassungen, um mit den sich ändernden Standards Schritt zu halten, was Ressourcen belasten und zu Verzögerungen bei der Produktentwicklung und Markteinführung führen kann. Diese Regulierungslast erhöht das Risiko der Nichteinhaltung, was kostspielige Folgen haben und den Marktzugang einschränken sowie die Zeit und Kosten für die Markteinführung von Produkten verlängern kann.
- Produkthaftungsrisiko und Sicherheitsbedenken
Obwohl Hilfsstoffe wesentliche Bestandteile von Nutraceutika-Formulierungen sind, ist ihre Sicherheit sehr wichtig. Hilfsstoffbedingte Nebenwirkungen oder Sicherheitsbedenken können zu Produktrückrufen, Rufschädigungen einer Marke und rechtlichen Konsequenzen für die Hersteller führen. Sorgen hinsichtlich Produkthaftung und -sicherheit können das Vertrauen der Verbraucher schädigen. Ungünstige Ereignisse, einschließlich dokumentierter Nebenwirkungen oder sicherheitsbezogener Streitigkeiten im Zusammenhang mit Nutraceutika, können die Kundenwahrnehmung stark beeinflussen, die Nachfrage senken und Misstrauen in die Branche schüren. Produkthaftungsbedenken können zu Rechtsstreitigkeiten, Gerichtsverfahren und Geldbußen führen. Die Stabilität und Rentabilität von Hilfsstoffherstellern können durch die erheblichen Kosten, die mit der Beilegung von Streitigkeiten oder der Verteidigung gegen Rechtsansprüche verbunden sind, negativ beeinflusst werden.
Jegliche Qualitätsabweichung, Sicherheitsbedenken oder ungünstige Reaktionen im Zusammenhang mit diesen Hilfsstoffen können schwerwiegende Folgen haben.
Jüngste Entwicklungen
- Im Oktober 2023 stellte Evonik Industries AG eine funktionsfähige, gebrauchsfertige orale Kapsel für präklinische Studien vor. Die 9-stündige (5,1 mm) präklinische magensaftresistente EUDRACAP-Kapsel ist eine Kapsel in technischer Qualität, die klein genug ist, um durch das Magen-Darm-System präklinischer Tiermodelle zu passen.
- Im Juli 2023 erweitern Evonik Industries AG und Heraeus Precious Metals das Leistungsspektrum beider Unternehmen für hochwirksame pharmazeutische Wirkstoffe (HPAPIs). Die Zusammenarbeit bietet Kunden eine vollständig integrierte Lösung, die von der präklinischen Forschung bis zur kommerziellen Herstellung reicht, indem sie die einzigartigen HPAPI-Fähigkeiten beider Unternehmen kombiniert.
Marktumfang für feste orale Nutraceutical-Hilfsstoffe in der EMEA-Region
Der Markt für feste orale Nutraceutika-Hilfsstoffe in der EMEA-Region ist anhand der Funktionalität, Formulierung, Endprodukt, Hilfsstoffquelle und Vertriebskanal in fünf wichtige Segmente unterteilt. Das Wachstum zwischen den Segmenten hilft Ihnen bei der Analyse von Wachstumsnischen und Strategien zur Marktbearbeitung sowie bei der Bestimmung Ihrer wichtigsten Anwendungsbereiche und der Unterschiede in Ihren Zielmärkten.
Funktionalität
- Bindemittel
- Füllstoffe & Verdünnungsmittel
- Suspensions- und Viskositätsmittel
- Beschichtungen
- Sprengmittel
- Sonstiges
Auf der Grundlage der Funktionalität ist der Markt in Bindemittel, Füllstoffe und Verdünnungsmittel, Suspensions- und Viskositätsmittel, Beschichtungen, Sprengmittel und Sonstiges segmentiert.
Formulierung
- Tablets
- Kapseln
- Gummibärchen
- Sonstiges
Auf Grundlage der Zusammensetzung ist der Markt in Tabletten, Kapseln, Gummibärchen und Sonstiges segmentiert.
Endprodukt
- Probiotika
- Präbiotika
- Protein- und Aminosäuren-Ergänzungsmittel
- Vitaminpräparate
- Mineralstoff-Ergänzungsmittel
- Omega-3-Ergänzungsmittel
- Andere Ergänzungen
Auf der Grundlage des Endprodukts ist der Markt in Probiotika, Präbiotika, Protein- und Aminosäurepräparate, Vitaminpräparate , Mineralstoffpräparate, Omega-3-Präparate und andere Präparate segmentiert.
Hilfsstoffquelle
- Synthetik
- Natürlich
Auf der Grundlage der Hilfsstoffquelle wird der Markt in synthetische und natürliche Stoffe segmentiert.
Vertriebskanal
- Direkte Ausschreibungen
- Einzelhandelsumsätze
- Sonstiges
Auf der Grundlage des Vertriebskanals wird der Markt in Direktausschreibungen, Einzelhandelsverkäufe und Sonstiges segmentiert.
EMEA-Markt für feste orale Nutraceutika-Hilfsstoffe: Regionale Analyse/Einblicke
Der Markt für feste orale Nutraceutika-Hilfsstoffe in der EMEA-Region ist in fünf wichtige Segmente unterteilt, nämlich Funktionalität, Formulierung, Endprodukt, Hilfsstoffquelle und Vertriebskanal.
Die in diesem Marktbericht abgedeckten Länder sind Deutschland, Italien, Großbritannien, Frankreich, Spanien, Belgien, Niederlande, Russland, Schweiz, Türkei, übriges Europa, Südafrika, Saudi-Arabien, Vereinigte Arabische Emirate, Algerien, Oman, Kuwait sowie der Rest des Nahen Ostens und Afrikas.
Aufgrund der starken Präsenz von Marktteilnehmern in der Region wird Deutschland voraussichtlich den Markt in der Region Europa dominieren.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit von EMEA-Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.
Wettbewerbsumfeld und Aktienanalyse: EMEA-Markt für feste orale Nutraceutical-Hilfsstoffe
Die Wettbewerbslandschaft des Marktes für feste orale Nutraceutika-Hilfsstoffe in EMEA bietet Details nach Wettbewerbern. Zu den Details gehören Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktzulassungen, Produktbreite und -breite, Anwendungsdominanz, Produkttyp-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf den Markt für feste orale Nutraceutika-Hilfsstoffe in EMEA.
Zu den wichtigsten Akteuren auf dem Markt für feste orale Nutraceutika-Hilfsstoffe in der EMEA-Region zählen unter anderem Ingredion, Azelis, JRS Pharma, BASF Corporation, Omya, Ashland, DuPont, Sigachi Industries, International Flavors & Fragrances Inc., Croda International Plc, Cargill, Incorporated., Grain Processing Corporation, Kerry Group plc, Roquette Frères, Colorcon, Bioground GmbH, BENEO (eine Tochtergesellschaft der Südzucker AG), Evonik Industries AG und SEPPIC.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TREATMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET FUNCTIONALITY COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S MODEL OF FIVE FORCES
4.3 ANALYSIS OF POLYMERS AND THEIR PURPOSE FOR VARIOUS INDUSTRY VERTICALS
5 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, REGULATORY FRAMEWORK
5.1 REGULATIONS IN EUROPE
5.2 REGULATIONS IN AFRICA
5.3 REGULATIONS IN THE MIDDLE EAST
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING DEMAND FOR NUTRACEUTICAL PRODUCTS
6.1.2 RISING ADVANCEMENTS IN NUTRACEUTICAL EXCIPIENTS
6.1.3 INCREASING GOVERNMENT INITIATIVES AND AWARENESS CAMPAIGNS
6.1.4 INCREASING APPLICATIONS OF PREBIOTICS AND PROBIOTICS
6.2 RESTRAINTS
6.2.1 REGULATORY COMPLIANCE FOR NUTRACEUTICALS EXCIPIENTS
6.2.2 SUBSTANTIAL EXPENSES ASSOCIATED WITH DEVELOPMENT AND PRODUCTION
6.3 OPPORTUNITIES
6.3.1 GROWING HEALTH AWARENESS AMONG THE POPULATION
6.3.2 RISING STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.3.3 GROWING DEMAND FOR PERSONALIZED PRODUCTS
6.4 CHALLENGES
6.4.1 RISK OF PRODUCT LIABILITY AND SAFETY CONCERNS
6.4.2 DISTURBANCE IN SUPPLY CHAIN AND LOGISTICS MANAGEMENT
7 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY
7.1 OVERVIEW
7.2 COATINGS
7.2.1 BY POLYMER
7.2.1.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC)
7.2.1.2 ETHYLCELLULOSE
7.2.1.3 POLYVINYL ALCOHOL (PVA)
7.2.1.4 ACRYLIC POLYMERS (EUDRAGIT)
7.2.1.5 SHELLAC
7.2.1.6 TITANIUM DIOXIDE
7.2.1.7 POLYETHYLENE GLYCOL (PEG)
7.2.1.8 CELLULOSE ACETATE PHTHALATE (CAP)
7.2.1.9 TALC
7.2.2 BY TYPE
7.2.2.1 NON-FUNCTIONAL COATINGS
7.2.2.2 FUNCTIONAL COATINGS
7.2.3 BY CATEGORY
7.2.3.1 OUT-HOUSE
7.2.3.2 IN-HOUSE
7.3 BINDERS
7.3.1 BY POLYMER
7.3.1.1 POVIDONE (POLYVINYLPYRROLIDONE, PVP)
7.3.1.2 HYDROXYPROPYL CELLUCLOSE (HPC)
7.3.1.3 MICROCRYSTALLINE CELLULOSE
7.3.1.4 STARCH (CORNSTARCH OR PREGELATINIZED STARCH)
7.3.1.5 METHYLCELLULOSE
7.4 DISINTEGRANTS
7.4.1 BY POLYMER
7.4.1.1 CROSPOVIDONE (POLYPLASDONE)
7.4.1.2 CROSSLINKED POVIDONE (PVPP)
7.4.1.3 STARCH
7.4.1.4 SODIUM STARCH GLYCOLATE (SSG)
7.4.1.5 CROSCARMELLOSE SODIUM
7.4.1.6 MANNITOL
7.4.1.7 LACTOSE
7.4.1.8 SODIUM CARBOXYMETHYLCELLULOSE (NA-CMC)
7.4.1.9 COLLOIDAL SILICON DIOXIDE
7.4.1.10 GLYCERYL BEHENATE
7.5 FILLERS & DILUENTS
7.5.1 BY POLYMER
7.5.1.1 LACTOSE
7.5.1.2 SORBITOL
7.5.1.3 MANNITOL
7.5.1.4 DEXTROSE (GLUCOSE)
7.5.1.5 SUCROSE
7.5.1.6 MALTODEXTRIN
7.5.1.7 MICROCRYSTALLINE CELLULOSE
7.5.1.8 DICALCIUM PHOSPHATE
7.5.1.9 CALCIUM SULFATE (DIHYDRATE AND ANHYDROUS)
7.5.1.10 SODIUM CHLORIDE (SALT)
7.6 SUSPENSION & VISCOSITY AGENTS
7.6.1 BY POLYMER
7.6.1.1 CARBOXYMETHYLCELLULOSE SODIUM
7.6.1.2 HYDROXYETHYLCELLULOSE (HEC)
7.6.1.3 ACACIA GUM (GUM ARABIC)
7.6.1.4 XANTHAN GUM
7.6.1.5 SODIUM ALGINATE
7.6.1.6 BENTONITE
7.6.1.7 SILICON DIOXIDE (COLLOIDAL)
7.6.1.8 SODIUM CARBOXYMETHYL STARCH
7.6.1.9 VEEGUM
7.6.1.10 PECTIN
7.7 OTHERS
8 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION
8.1 OVERVIEW
8.2 TABLETS
8.3 CAPSULES
8.4 GUMMIES
8.5 OTHERS
9 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT
9.1 OVERVIEW
9.2 VITAMIN SUPPLEMENTS
9.3 MINERAL SUPPLEMENTS
9.4 PROTEIN AND AMINO ACID SUPPLEMENTS
9.5 PROBIOTICS
9.6 PREBIOTICS
9.7 OMEGA-3 SUPPLEMENTS
9.8 OTHER SUPPLEMENTS
10 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SORCE
10.1 OVERVIEW
10.2 SYNTHETIC
10.3 NATURAL
10.4 PLANT
10.5 MINERAL
10.6 ANIMAL
11 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 MASS MERCHANDISE
11.5 ONLINE STORES
11.6 OTHERS
11.7 OTHERS
12 EMEA SOLID ORAL NUTRACEUTICALS EXCIPIENT MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 ITALY
12.1.3 U.K.
12.1.4 FRANCE
12.1.5 SPAIN
12.1.6 BELGIUM
12.1.7 NETHERLANDS
12.1.8 RUSSIA
12.1.9 SWITZERLAND
12.1.10 TURKEY
12.1.11 REST OF EUROPE
12.2 MIDDLE EAST AND AFRICA
12.2.1 SOUTH AFRICA
12.2.2 SAUDI ARABIA
12.2.3 U.A.E.
12.2.4 ALGERIA
12.2.5 OMAN
12.2.6 KUWAIT
12.2.7 REST OF MIDDLE EAST AND AFRICA
12.3 PAKISTAN
13 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EMEA
14 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 MEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 KERRY GROUP PLC
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 DUPONT
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 CARGILL, INCORPORATED
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY REVENUE & VOLUME ANALYSIS, BY FUNCTIONALITY
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 BASF CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 INGREDION
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 ASHLAND
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENT
17.7 AZELIS
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 COMPANY REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENT
17.8 BENEO (A SUBSIDIARY OF SUDZUCKER AG)
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 COMPANY REVENUE & VOLUME ANALYSIS, BY FUNCTIONALITY
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENT
17.9 BIOGROUND GMBH
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 COLORCON
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 CRODA INTERNATIONAL PLC
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.11.4 PRODUCT PORTFOLIO
17.11.5 RECENT DEVELOPMENT
17.12 EVONIK INDUSTRIES AG
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.12.4 PRODUCT PORTFOLIO
17.12.5 RECENT DEVELOPMENT
17.13 GRAIN PROCESSING CORPORATION
17.13.1 COMPANY SNAPSHOT
17.13.2 COMPANY REVENUE & VOLUME ANALYSIS, BY FUNCTIONALITY
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 INTERNATIONAL FLAVORS & FRAGRANCES INC.
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENT
17.15 JRS PHARMA
17.15.1 COMPANY SNAPSHOT
17.15.2 COMPANY REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 OMYA
17.16.1 COMPANY SNAPSHOT
17.16.2 COMPANY REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENT
17.17 ROQUETTE FRERES
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
17.18 SEPPIC
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 SIGACHI INDUSTRIES
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 REVENUE AND VOLUME ANALYSIS, BY FUNCTIONALITY
17.19.4 PRODUCT PORTFOLIO
17.19.5 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD THOUSAND)
TABLE 2 EMEA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 3 EMEA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 4 EMEA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 5 EMEA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 6 EMEA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 7 EMEA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 8 EMEA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 9 EMEA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 10 EMEA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 11 EMEA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 12 EMEA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 13 EMEA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 14 EMEA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 15 EMEA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 16 EMEA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 17 EMEA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 18 EMEA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 19 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022- 2031 (USD THOUSAND)
TABLE 20 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022- 2031 (USD THOUSAND)
TABLE 21 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022- 2031 (USD THOUSAND)
TABLE 22 EMEA NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022- 2031 (USD THOUSAND)
TABLE 23 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022- 2031 (USD THOUSAND)
TABLE 24 EMEA RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022- 2031 (USD THOUSAND)
TABLE 25 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 26 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 27 EUROPE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 28 EUROPE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 29 EUROPE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 30 EUROPE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 31 EUROPE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 32 EUROPE BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 33 EUROPE BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 34 EUROPE BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 35 EUROPE DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 36 EUROPE DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 37 EUROPE DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 38 EUROPE FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 39 EUROPE FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 40 EUROPE FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 41 EUROPE SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 42 EUROPE SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 43 EUROPE SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 44 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 45 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 46 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 47 EUROPE NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 49 EUROPE RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 50 GERMANY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 51 GERMANY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 52 GERMANY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 53 GERMANY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 54 GERMANY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 GERMANY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 56 GERMANY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 57 GERMANY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 58 GERMANY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 59 GERMANY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 60 GERMANY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 61 GERMANY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 62 GERMANY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 63 GERMANY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 64 GERMANY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 65 GERMANY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 66 GERMANY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 67 GERMANY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 68 GERMANY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 69 GERMANY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 70 GERMANY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 71 GERMANY NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 GERMANY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 73 GERMANY RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 74 ITALY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 75 ITALY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 76 ITALY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 77 ITALY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 78 ITALY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 ITALY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 80 ITALY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 81 ITALY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 82 ITALY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 83 ITALY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 84 ITALY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 85 ITALY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 86 ITALY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 87 ITALY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 88 ITALY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 89 ITALY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 90 ITALY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 91 ITALY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 92 ITALY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 93 ITALY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 94 ITALY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 95 ITALY NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 ITALY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 97 ITALY RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 98 U.K. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 99 U.K. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 100 U.K. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 101 U.K. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 102 U.K. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 103 U.K. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 104 U.K. BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 105 U.K. BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 106 U.K. BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 107 U.K. DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 108 U.K. DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 109 U.K. DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 110 U.K. FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 111 U.K. FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 112 U.K. FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 113 U.K. SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 114 U.K. SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 115 U.K. SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 116 U.K. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 117 U.K. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 118 U.K. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 119 U.K. NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 U.K. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 121 U.K. RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 122 FRANCE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 123 FRANCE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 124 FRANCE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 125 FRANCE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 126 FRANCE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 FRANCE COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 128 FRANCE BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 129 FRANCE BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 130 FRANCE BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 131 FRANCE DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 132 FRANCE DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 133 FRANCE DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 134 FRANCE FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 135 FRANCE FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 136 FRANCE FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 137 FRANCE SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 138 FRANCE SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 139 FRANCE SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 140 FRANCE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 141 FRANCE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 142 FRANCE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 143 FRANCE NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 FRANCE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 145 FRANCE RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 146 SPAIN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 147 SPAIN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 148 SPAIN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 149 SPAIN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 150 SPAIN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 151 SPAIN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 152 SPAIN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 153 SPAIN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 154 SPAIN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 155 SPAIN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 156 SPAIN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 157 SPAIN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 158 SPAIN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 159 SPAIN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 160 SPAIN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 161 SPAIN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 162 SPAIN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 163 SPAIN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 164 SPAIN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 165 SPAIN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 166 SPAIN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 167 SPAIN NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 SPAIN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 169 SPAIN RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 170 BELGIUM SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 171 BELGIUM COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 172 BELGIUM COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 173 BELGIUM COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 174 BELGIUM COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 BELGIUM COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 176 BELGIUM BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 177 BELGIUM BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 178 BELGIUM BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 179 BELGIUM DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 180 BELGIUM DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 181 BELGIUM DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 182 BELGIUM FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 183 BELGIUM FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 184 BELGIUM FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 185 BELGIUM SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 186 BELGIUM SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 187 BELGIUM SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 188 BELGIUM SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 189 BELGIUM SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 190 BELGIUM SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 191 BELGIUM NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 192 BELGIUM SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 193 BELGIUM RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 194 NETHERLANDS SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 195 NETHERLANDS COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 196 NETHERLANDS COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 197 NETHERLANDS COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 198 NETHERLANDS COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 NETHERLANDS COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 200 NETHERLANDS BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 201 NETHERLANDS BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 202 NETHERLANDS BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 203 NETHERLANDS DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 204 NETHERLANDS DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 205 NETHERLANDS DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 206 NETHERLANDS FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 207 NETHERLANDS FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 208 NETHERLANDS FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 209 NETHERLANDS SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 210 NETHERLANDS SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 211 NETHERLANDS SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 212 NETHERLANDS SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 213 NETHERLANDS SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 214 NETHERLANDS SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 215 NETHERLANDS NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 216 NETHERLANDS SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 217 NETHERLANDS RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 218 RUSSIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 219 RUSSIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 220 RUSSIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 221 RUSSIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 222 RUSSIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 223 RUSSIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 224 RUSSIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 225 RUSSIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 226 RUSSIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 227 RUSSIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 228 RUSSIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 229 RUSSIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 230 RUSSIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 231 RUSSIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 232 RUSSIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 233 RUSSIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 234 RUSSIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 235 RUSSIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 236 RUSSIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 237 RUSSIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 238 RUSSIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 239 RUSSIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 RUSSIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 241 RUSSIA RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 242 SWITZERLAND SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 243 SWITZERLAND COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 244 SWITZERLAND COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 245 SWITZERLAND COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 246 SWITZERLAND COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 247 SWITZERLAND COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 248 SWITZERLAND BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 249 SWITZERLAND BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 250 SWITZERLAND BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 251 SWITZERLAND DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 252 SWITZERLAND DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 253 SWITZERLAND DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 254 SWITZERLAND FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 255 SWITZERLAND FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 256 SWITZERLAND FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 257 SWITZERLAND SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 258 SWITZERLAND SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 259 SWITZERLAND SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 260 SWITZERLAND SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 261 SWITZERLAND SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 262 SWITZERLAND SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 263 SWITZERLAND NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 264 SWITZERLAND SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 265 SWITZERLAND RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 266 TURKEY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 267 TURKEY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 268 TURKEY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 269 TURKEY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 270 TURKEY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 271 TURKEY COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 272 TURKEY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 273 TURKEY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 274 TURKEY BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 275 TURKEY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 276 TURKEY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 277 TURKEY DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 278 TURKEY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 279 TURKEY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 280 TURKEY FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 281 TURKEY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 282 TURKEY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 283 TURKEY SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 284 TURKEY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 285 TURKEY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 286 TURKEY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 287 TURKEY NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 TURKEY SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 289 TURKEY RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 290 REST OF EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 291 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 292 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 293 MIDDLE EAST AND AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 294 MIDDLE EAST AND AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 295 MIDDLE EAST AND AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 296 MIDDLE EAST AND AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 297 MIDDLE EAST AND AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 298 MIDDLE EAST AND AFRICA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 299 MIDDLE EAST AND AFRICA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 300 MIDDLE EAST AND AFRICA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 301 MIDDLE EAST AND AFRICA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 302 MIDDLE EAST AND AFRICA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 303 MIDDLE EAST AND AFRICA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 304 MIDDLE EAST AND AFRICA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 305 MIDDLE EAST AND AFRICA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 306 MIDDLE EAST AND AFRICA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 307 MIDDLE EAST AND AFRICA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 308 MIDDLE EAST AND AFRICA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 309 MIDDLE EAST AND AFRICA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 310 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 311 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 312 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 313 MIDDLE EAST AND AFRICA NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 314 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 315 MIDDLE EAST AND AFRICA RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 316 SOUTH AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 317 SOUTH AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 318 SOUTH AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 319 SOUTH AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 320 SOUTH AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 321 SOUTH AFRICA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 322 SOUTH AFRICA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 323 SOUTH AFRICA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 324 SOUTH AFRICA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 325 SOUTH AFRICA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 326 SOUTH AFRICA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 327 SOUTH AFRICA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 328 SOUTH AFRICA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 329 SOUTH AFRICA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 330 SOUTH AFRICA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 331 SOUTH AFRICA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 332 SOUTH AFRICA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 333 SOUTH AFRICA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 334 SOUTH AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 335 SOUTH AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 336 SOUTH AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 337 SOUTH AFRICA NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 338 SOUTH AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 339 SOUTH AFRICA RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 340 SAUDI ARABIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 341 SAUDI ARABIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 342 SAUDI ARABIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 343 SAUDI ARABIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 344 SAUDI ARABIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 345 SAUDI ARABIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 346 SAUDI ARABIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 347 SAUDI ARABIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 348 SAUDI ARABIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 349 SAUDI ARABIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 350 SAUDI ARABIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 351 SAUDI ARABIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 352 SAUDI ARABIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 353 SAUDI ARABIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 354 SAUDI ARABIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 355 SAUDI ARABIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 356 SAUDI ARABIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 357 SAUDI ARABIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 358 SAUDI ARABIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 359 SAUDI ARABIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 360 SAUDI ARABIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 361 SAUDI ARABIA NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 362 SAUDI ARABIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 363 SAUDI ARABIA RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 364 U.A.E. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 365 U.A.E. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 366 U.A.E. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 367 U.A.E. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 368 U.A.E. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 369 U.A.E. COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 370 U.A.E. BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 371 U.A.E. BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 372 U.A.E. BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 373 U.A.E. DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 374 U.A.E. DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 375 U.A.E. DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 376 U.A.E. FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 377 U.A.E. FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 378 U.A.E. FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 379 U.A.E. SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 380 U.A.E. SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 381 U.A.E. SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 382 U.A.E. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 383 U.A.E. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 384 U.A.E. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 385 U.A.E. NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 386 U.A.E. SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 387 U.A.E. RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 388 ALGERIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 389 ALGERIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 390 ALGERIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 391 ALGERIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 392 ALGERIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 393 ALGERIA COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 394 ALGERIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 395 ALGERIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 396 ALGERIA BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 397 ALGERIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 398 ALGERIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 399 ALGERIA DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 400 ALGERIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 401 ALGERIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 402 ALGERIA FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 403 ALGERIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 404 ALGERIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 405 ALGERIA SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 406 ALGERIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 407 ALGERIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 408 ALGERIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 409 ALGERIA NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 410 ALGERIA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 411 ALGERIA RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 412 OMAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 413 OMAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 414 OMAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 415 OMAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 416 OMAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 417 OMAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 418 OMAN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 419 OMAN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 420 OMAN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 421 OMAN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 422 OMAN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 423 OMAN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 424 OMAN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 425 OMAN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 426 OMAN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 427 OMAN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 428 OMAN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 429 OMAN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 430 OMAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 431 OMAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 432 OMAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 433 OMAN NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 434 OMAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 435 OMAN RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 436 KUWAIT SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 437 KUWAIT COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 438 KUWAIT COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 439 KUWAIT COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 440 KUWAIT COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 441 KUWAIT COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 442 KUWAIT BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 443 KUWAIT BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 444 KUWAIT BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 445 KUWAIT DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 446 KUWAIT DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 447 KUWAIT DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 448 KUWAIT FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 449 KUWAIT FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 450 KUWAIT FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 451 KUWAIT SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 452 KUWAIT SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 453 KUWAIT SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 454 KUWAIT SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 455 KUWAIT SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 456 KUWAIT SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 457 KUWAIT NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 458 KUWAIT SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 459 KUWAIT RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 460 REST OF MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 461 PAKISTAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 462 PAKISTAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 463 PAKISTAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 464 PAKISTAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 465 PAKISTAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 466 PAKISTAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 467 PAKISTAN COATINGS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 468 PAKISTAN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 469 PAKISTAN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 470 PAKISTAN BINDERS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 471 PAKISTAN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 472 PAKISTAN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 473 PAKISTAN DISINTEGRANTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 474 PAKISTAN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 475 PAKISTAN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 476 PAKISTAN FILLERS & DILUENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 477 PAKISTAN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (USD THOUSAND)
TABLE 478 PAKISTAN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (VOLUME)
TABLE 479 PAKISTAN SUSPENSION & VISCOSITY AGENTS IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY POLYMER, 2022-2031 (ASP IN USD/KG)
TABLE 480 PAKISTAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY FORMULATION, 2022-2031 (USD THOUSAND)
TABLE 481 PAKISTAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 482 PAKISTAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY EXCIPIENT SOURCE, 2022-2031 (USD THOUSAND)
TABLE 483 PAKISTAN NATURAL IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 484 PAKISTAN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 485 PAKISTAN RETAIL SALES IN SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
Abbildungsverzeichnis
FIGURE 1 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: SEGMENTATION
FIGURE 2 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: DATA TRIANGULATION
FIGURE 3 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: DROC ANALYSIS
FIGURE 4 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: MARKET FUNCTIONALITY COVERAGE GRID
FIGURE 9 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR NUTRITIONAL SUPPLEMENTS AND FORTIFIED FOOD PRODUCTS IS DRIVING THE GROWTH OF THE EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 12 THE FUNCTIONALITY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET IN THE FORECAST PERIOD OF 2024 AND 2031
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET
FIGURE 14 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FUNCTIONALITY, 2023
FIGURE 15 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FUNCTIONALITY, 2024-2031 (USD MILLION)
FIGURE 16 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FUNCTIONALITY, CAGR (2024-2031)
FIGURE 17 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FUNCTIONALITY, LIFELINE CURVE
FIGURE 18 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FORMULATION, 2023
FIGURE 19 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FORMULATION, 2024-2031 (USD THOUSAND)
FIGURE 20 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FORMULATION, CAGR (2024-2031)
FIGURE 21 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY FORMULATION, LIFELINE CURVE
FIGURE 22 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY END PRODUCT, 2023
FIGURE 23 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY END PRODUCT, 2024-2031 (USD THOUSAND)
FIGURE 24 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY END PRODUCT, CAGR (2024-2031)
FIGURE 25 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY END PRODUCT, LIFELINE CURVE
FIGURE 26 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY EXCIPIENT SOURCE, 2023
FIGURE 27 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY EXCIPIENT SOURCE, 2024-2031 (USD THOUSAND)
FIGURE 28 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY EXCIPIENT SOURCE, CAGR (2024-2031)
FIGURE 29 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY EXCIPIENT SOURCE, LIFELINE CURVE
FIGURE 30 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 31 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 32 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 33 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EMEA SOLID ORAL NUTRACEUTICALS EXCIPIENT MARKET: SNAPSHOT (2023)
FIGURE 35 EMEA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 EUROPE SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY SHARE 2023 (%)
FIGURE 37 MIDDLE EAST AND AFRICA SOLID ORAL NUTRACEUTICAL EXCIPIENT MARKET: COMPANY SHARE 2023 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
